Medical Morphine Market Size, Share, Trends, Growth Outlook

The Medical Morphine Market Size is estimated to register 7.9% growth over the forecast period from 2024 to 2030.

 

Medical Morphine Market Overview

The increasing prevalence of chronic pain conditions, such as cancer-related pain and post-surgical pain are necessitating the use of potent analgesics like morphine for effective pain management. The aging global population is also playing a crucial role, as elderly individuals often experience chronic conditions that require long-term pain relief. Moreover, advancements in medical interventions and surgical procedures are contributing to the rising demand for morphine as a postoperative analgesic. Continuous efforts to enhance the safety, efficacy, and convenience of morphine administration are leading to the introduction of novel formulations, such as extended-release or abuse-deterrent formulations. The opioid's effectiveness in providing pain relief, especially in severe and persistent pain scenarios is positioning it as a cornerstone in palliative care and end-of-life pain management. Further, Healthcare professionals are receiving updated training on assessing pain, understanding the appropriate use of opioids, and implementing comprehensive pain management plans.

 

Medical Morphine Market Dynamics

Market Trends- Diversification of Pain Management Options in the Medical Morphine Market

Industry-wide acknowledgment of the need for a comprehensive and tailored approach to pain relief, considering the varied nature and intensity of pain experienced by patients are propelling the market. Pharmaceutical companies are increasingly focusing on the development of innovative formulations and delivery methods to offer a spectrum of morphine-based products that cater to diverse patient needs. Additionally, diversification including extended-release formulations for prolonged pain control, combination therapies that enhance efficacy, and alternative routes of administration to accommodate patient preferences are gaining traction.

 

Market Driver- The Medical Morphine market is growing in response to the rising incidence of chronic pain cases

As the global population ages and the incidence of chronic health conditions such as cancer, arthritis, and neurological disorders rises, the demand for potent analgesics like morphine is intensifying. Chronic pain, characterized by its persistent nature and often debilitating impact on patients' quality of life are necessitating effective pharmacological interventions making morphine as a primary choice for severe and enduring pain management. Further, the growing healthcare challenge of chronic pain are compelling pharmaceutical companies and healthcare providers to align their strategies to meet the escalating demand.

 

Market Opportunity- Advancements in palliative care underscores the crucial role of Medical Morphine

Heightened focus on enhancing the quality of life for patients with serious illnesses, emphasizing comprehensive and compassionate end-of-life care are driving the market. The rise in palliative care prominence is increasing the demand for potent analgesics like morphine is becoming pivotal in managing pain and improving the overall well-being of patients facing life-limiting conditions. Further, Pharmaceutical companies, recognizing the evolving needs of palliative care, are actively engaged in developing innovative formulations and delivery methods for morphine, ensuring optimal efficacy and patient comfort.

 

Market Share Analysis- Injection will register the fastest growth

The Medical Morphine Market is analyzed across Injection, Oral Tablets, and Others. Injection is poised to register the fastest growth. With its rapid onset of action, injectable morphine is often preferred in acute settings such as hospitals, emergency departments, and postoperative care. This dosage form allows healthcare professionals to administer precise and controlled doses, ensuring effective pain relief for patients dealing with severe pain episodes. Additionally, the injection format is vital in situations where rapid and reliable pain relief is paramount, such as in cases of trauma or critical care. Pharmaceutical companies are continually innovating in this segment, developing advanced formulations and delivery systems to enhance the safety and efficacy of injectable morphine. The injection form's prominence in the Medical Morphine Market underscores its significance in providing swift and targeted pain management solutions across diverse medical contexts.

 

Market Share Analysis- Pain Management held a significant market share in 2024

The Medical Morphine Market is analyzed across various Applications including Pain Management, Diarrhea Suppressant, Cold and Cough Suppressant, and Others. Of these, SMEs held a significant market share in 2024. As a potent opioid analgesic, morphine is widely employed for managing moderate to severe pain arising from diverse medical conditions, including postoperative recovery, cancer-related pain, and chronic illnesses. Its efficacy in providing profound pain relief makes it a cornerstone in pain management protocols across different healthcare settings. The versatility of morphine allows for varied administration routes, including oral tablets and injectable forms, catering to the specific needs of patients and the nature of their pain. Pharmaceutical companies continually focus on refining formulations and delivery methods to optimize morphine's therapeutic benefits and minimize potential side effects. The sustained demand for morphine in pain management highlights its irreplaceable position in addressing the complex and multifaceted challenge of pain, contributing significantly to enhancing patients' quality of life and overall well-being.

 

Medical Morphine Market News

On June 20, 2023, the U.S. Food and Drug Administration (FDA) granted approval to Endo Pharmaceuticals for their innovative PERSISTIR (morphine sulfate extended-release) tablets.

On October 18, 2023, the World Health Organization (WHO) issued a compelling report shedding light on the critical issue of inadequate access to essential pain medications, particularly morphine, in numerous low- and middle-income countries.

 

Medical Morphine Market Segmentation

By Dosage Form

• Injection
• Oral Tablets
• Others

 

By Application

• Pain Management
  • Cancer Pain
  • Neuropathic Pain
  • Osteoarthritis Pain
  • Others

• Diarrhea Suppressant
• Cold and Cough Suppressant
• Others

 

By Region

• North America (United States, Canada, Mexico)
• Europe (Germany, France, United Kingdom, Spain, Italy, Others)
• Asia Pacific (China, India, Japan, South Korea, Australia, Others)
• Latin America (Brazil, Argentina, Others)
• Middle East and Africa (Saudi Arabia, UAE, Kuwait, Other Middle East, South Africa, Nigeria, Other Africa)

 

Medical Morphine Market Companies

• Mallinckrodt Pharmaceuticals
• Pfizer Inc
• Sun Pharmaceutical Industries Ltd
• AbbVie Inc
• Delpharm (Sandoz Canada Inc.)
• Dr. Reddy's Laboratories Ltd (Mayne Pharma Group Limited)
• Daiichi Sankyo Company Limited
• Verve Health Care Ltd
• Hikma Pharmaceuticals USA Inc
• Viatris Inc
• Alcaliber S.A
• Sanofi

 

*List not exhaustive

 

Medical Morphine Market Outlook 2023

1 Market Overview

1.1 Introduction to the Medical Morphine Market

1.2 Scope of the Study

1.3 Research Objective

1.3.1 Key Market Scope and Segments

1.3.2 Players Covered

1.3.3 Years Considered

 

2 Executive Summary

2.1 2023 Medical Morphine Industry- Market Statistics

3 Market Dynamics

3.1 Market Drivers

3.2 Market Challenges

3.3 Market Opportunities

3.4 Market Trends

 

4 Market Factor Analysis

4.1 Porter’s Five Forces

4.2 Market Entropy

4.2.1 Global Medical Morphine Market Companies with Area Served

4.2.2 Products Offerings Global Medical Morphine Market

 

5 COVID-19 Impact Analysis and Outlook Scenarios

5.1.1 Covid-19 Impact Analysis

5.1.2 Post-COVID-19 Scenario- Low Growth Case

5.1.3 Post-COVID-19 Scenario- Reference Growth Case

5.1.4 Post-COVID-19 Scenario- Low Growth Case

 

6 Global Medical Morphine Market Trends

6.1 Global Medical Morphine Revenue (USD Million) and CAGR (%) by Type (2018-2030)

6.2 Global Medical Morphine Revenue (USD Million) and CAGR (%) by Applications (2018-2030)

6.3 Global Medical Morphine Revenue (USD Million) and CAGR (%) by Regions (2018-2030)

 

7 Global Medical Morphine Market Revenue (USD Million) by Type, and Applications (2018-2022)

7.1 Global Medical Morphine Revenue (USD Million) by Type (2018-2022)

7.1.1 Global Medical Morphine Revenue (USD Million), Market Share (%) by Type (2018-2022)

7.2 Global Medical Morphine Revenue (USD Million) by Applications (2018-2022)

7.2.1 Global Medical Morphine Revenue (USD Million), Market Share (%) by Applications (2018-2022)

 

8 Global Medical Morphine Development Regional Status and Outlook

8.1 Global Medical Morphine Revenue (USD Million) By Regions (2018-2022)

8.2 North America Medical Morphine Revenue (USD Million) by Type, and Application (2018-2022)

8.2.1 North America Medical Morphine Revenue (USD Million) by Country (2018-2022)

8.2.2 North America Medical Morphine Revenue (USD Million) by Type (2018-2022)

8.2.3 North America Medical Morphine Revenue (USD Million) by Applications (2018-2022)

8.3 Europe Medical Morphine Revenue (USD Million), by Type, and Applications (USD Million) (2018-2022)

8.3.1 Europe Medical Morphine Revenue (USD Million), by Country (2018-2022)

8.3.2 Europe Medical Morphine Revenue (USD Million) by Type (2018-2022)

8.3.3 Europe Medical Morphine Revenue (USD Million) by Applications (2018-2022)

8.4 Asia Pacific Medical Morphine Revenue (USD Million), and Revenue (USD Million) by Type, and Applications (2018-2022)

8.4.1 Asia Pacific Medical Morphine Revenue (USD Million) by Country (2018-2022)

8.4.2 Asia Pacific Medical Morphine Revenue (USD Million) by Type (2018-2022)

8.4.3 Asia Pacific Medical Morphine Revenue (USD Million) by Applications (2018-2022)

8.5 South America Medical Morphine Revenue (USD Million), by Type, and Applications (2018-2022)

8.5.1 South America Medical Morphine Revenue (USD Million), by Country (2018-2022)

8.5.2 South America Medical Morphine Revenue (USD Million) by Type (2018-2022)

8.5.3 South America Medical Morphine Revenue (USD Million) by Applications (2018-2022)

8.6 Middle East and Africa Medical Morphine Revenue (USD Million), by Type, Technology, Application, Thickness (2018-2022)

8.6.1 Middle East and Africa Medical Morphine Revenue (USD Million) by Country (2018-2022)

8.6.2 Middle East and Africa Medical Morphine Revenue (USD Million) by Type (2018-2022)

8.6.3 Middle East and Africa Medical Morphine Revenue (USD Million) by Applications (2018-2022)

 

9 Company Profiles

 

10 Global Medical Morphine Market Revenue (USD Million), by Type, and Applications (2023-2030)

10.1 Global Medical Morphine Revenue (USD Million) and Market Share (%) by Type (2023-2030)

10.1.1 Global Medical Morphine Revenue (USD Million), and Market Share (%) by Type (2023-2030)

10.2 Global Medical Morphine Revenue (USD Million) and Market Share (%) by Applications (2023-2030)

10.2.1 Global Medical Morphine Revenue (USD Million), and Market Share (%) by Applications (2023-2030)

 

11 Global Medical Morphine Development Regional Status and Outlook Forecast

11.1 Global Medical Morphine Revenue (USD Million) By Regions (2023-2030)

11.2 North America Medical Morphine Revenue (USD Million) by Type, and Applications (2023-2030)

11.2.1 North America Medical Morphine Revenue (USD) Million by Country (2023-2030)

11.2.2 North America Medical Morphine Revenue (USD Million), by Type (2023-2030)

11.2.3 North America Medical Morphine Revenue (USD Million), Market Share (%) by Applications (2023-2030)

11.3 Europe Medical Morphine Revenue (USD Million), by Type, and Applications (2023-2030)

11.3.1 Europe Medical Morphine Revenue (USD Million), by Country (2023-2030)

11.3.2 Europe Medical Morphine Revenue (USD Million), by Type (2023-2030)

11.3.3 Europe Medical Morphine Revenue (USD Million), by Applications (2023-2030)

11.4 Asia Pacific Medical Morphine Revenue (USD Million) by Type, and Applications (2023-2030)

11.4.1 Asia Pacific Medical Morphine Revenue (USD Million), by Country (2023-2030)

11.4.2 Asia Pacific Medical Morphine Revenue (USD Million), by Type (2023-2030)

11.4.3 Asia Pacific Medical Morphine Revenue (USD Million), by Applications (2023-2030)

11.5 South America Medical Morphine Revenue (USD Million), by Type, and Applications (2023-2030)

11.5.1 South America Medical Morphine Revenue (USD Million), by Country (2023-2030)

11.5.2 South America Medical Morphine Revenue (USD Million), by Type (2023-2030)

11.5.3 South America Medical Morphine Revenue (USD Million), by Applications (2023-2030)

11.6 Middle East and Africa Medical Morphine Revenue (USD Million), by Type, and Applications (2023-2030)

11.6.1 Middle East and Africa Medical Morphine Revenue (USD Million), by Region (2023-2030)

11.6.2 Middle East and Africa Medical Morphine Revenue (USD Million), by Type (2023-2030)

11.6.3 Middle East and Africa Medical Morphine Revenue (USD Million), by Applications (2023-2030)

 

12 Methodology and Data Sources

12.1 Methodology/Research Approach

12.1.1 Research Programs/Design

12.1.2 Market Size Estimation

12.1.3 Market Breakdown and Data Triangulation

12.2 Data Sources

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Disclaimer

 

List of Tables

Table 1 Market Segmentation Analysis

Table 2 Global Medical Morphine Market Companies with Areas Served

Table 3 Products Offerings Global Medical Morphine Market

Table 4 Low Growth Scenario Forecasts

Table 5 Reference Case Growth Scenario

Table 6 High Growth Case Scenario

Table 7 Global Medical Morphine Revenue (USD Million) And CAGR (%) By Type (2018-2030)

Table 8 Global Medical Morphine Revenue (USD Million) And CAGR (%) By Applications (2018-2030)

Table 9 Global Medical Morphine Revenue (USD Million) And CAGR (%) By Regions (2018-2030)

Table 10 Global Medical Morphine Revenue (USD Million) By Type (2018-2022)

Table 11 Global Medical Morphine Revenue Market Share (%) By Type (2018-2022)

Table 12 Global Medical Morphine Revenue (USD Million) By Applications (2018-2022)

Table 13 Global Medical Morphine Revenue Market Share (%) By Applications (2018-2022)

Table 14 Global Medical Morphine Market Revenue (USD Million) By Regions (2018-2022)

Table 15 Global Medical Morphine Market Share (%) By Regions (2018-2022)

Table 16 North America Medical Morphine Revenue (USD Million) By Country (2018-2022)

Table 17 North America Medical Morphine Revenue (USD Million) By Type (2018-2022)

Table 18 North America Medical Morphine Revenue (USD Million) By Applications (2018-2022)

Table 19 Europe Medical Morphine Revenue (USD Million) By Country (2018-2022)

Table 20 Europe Medical Morphine Revenue (USD Million) By Type (2018-2022)

Table 21 Europe Medical Morphine Revenue (USD Million) By Applications (2018-2022)

Table 22 Asia Pacific Medical Morphine Revenue (USD Million) By Country (2018-2022)

Table 23 Asia Pacific Medical Morphine Revenue (USD Million) By Type (2018-2022)

Table 24 Asia Pacific Medical Morphine Revenue (USD Million) By Applications (2018-2022)

Table 25 South America Medical Morphine Revenue (USD Million) By Country (2018-2022)

Table 26 South America Medical Morphine Revenue (USD Million) By Type (2018-2022)

Table 27 South America Medical Morphine Revenue (USD Million) By Applications (2018-2022)

Table 28 Middle East and Africa Medical Morphine Revenue (USD Million) By Region (2018-2022)

Table 29 Middle East and Africa Medical Morphine Revenue (USD Million) By Type (2018-2022)

Table 30 Middle East and Africa Medical Morphine Revenue (USD Million) By Applications (2018-2022)

Table 31 Financial Analysis

Table 32 Global Medical Morphine Revenue (USD Million) By Type (2023-2030)

Table 33 Global Medical Morphine Revenue Market Share (%) By Type (2023-2030)

Table 34 Global Medical Morphine Revenue (USD Million) By Applications (2023-2030)

Table 35 Global Medical Morphine Revenue Market Share (%) By Applications (2023-2030)

Table 36 Global Medical Morphine Market Revenue (USD Million), And Revenue (USD Million) By Regions (2023-2030)

Table 37 North America Medical Morphine Revenue (USD)By Country (2023-2030)

Table 38 North America Medical Morphine Revenue (USD Million) By Type (2023-2030)

Table 39 North America Medical Morphine Revenue (USD Million) By Applications (2023-2030)

Table 40 Europe Medical Morphine Revenue (USD Million) By Country (2023-2030)

Table 41 Europe Medical Morphine Revenue (USD Million) By Type (2023-2030)

Table 42 Europe Medical Morphine Revenue (USD Million) By Applications (2023-2030)

Table 43 Asia Pacific Medical Morphine Revenue (USD Million) By Country (2023-2030)

Table 44 Asia Pacific Medical Morphine Revenue (USD Million) By Type (2023-2030)

Table 45 Asia Pacific Medical Morphine Revenue (USD Million) By Applications (2023-2030)

Table 46 South America Medical Morphine Revenue (USD Million) By Country (2023-2030)

Table 47 South America Medical Morphine Revenue (USD Million) By Type (2023-2030)

Table 48 South America Medical Morphine Revenue (USD Million) By Applications (2023-2030)

Table 49 Middle East and Africa Medical Morphine Revenue (USD Million) By Region (2023-2030)

Table 50 Middle East and Africa Medical Morphine Revenue (USD Million) By Region (2023-2030)

Table 51 Middle East and Africa Medical Morphine Revenue (USD Million) By Type (2023-2030)

Table 52 Middle East and Africa Medical Morphine Revenue (USD Million) By Applications (2023-2030)

Table 53 Research Programs/Design for This Report

Table 54 Key Data Information from Secondary Sources

Table 55 Key Data Information from Primary Sources

 

List of Figures

Figure 1 Market Scope

Figure 2 Porter’s Five Forces

Figure 3 Global Medical Morphine Revenue (USD Million) By Type (2018-2022)

Figure 4 Global Medical Morphine Revenue Market Share (%) By Type (2022)

Figure 5 Global Medical Morphine Revenue (USD Million) By Applications (2018-2022)

Figure 6 Global Medical Morphine Revenue Market Share (%) By Applications (2022)

Figure 7 Global Medical Morphine Market Revenue (USD Million) By Regions (2018-2022)

Figure 8 Global Medical Morphine Market Share (%) By Regions (2022)

Figure 9 North America Medical Morphine Revenue (USD Million) By Country (2018-2022)

Figure 10 North America Medical Morphine Revenue (USD Million) By Type (2018-2022)

Figure 11 North America Medical Morphine Revenue (USD Million) By Applications (2018-2022)

Figure 12 Europe Medical Morphine Revenue (USD Million) By Country (2018-2022)

Figure 13 Europe Medical Morphine Revenue (USD Million) By Type (2018-2022)

Figure 14 Europe Medical Morphine Revenue (USD Million) By Applications (2018-2022)

Figure 15 Asia Pacific Medical Morphine Revenue (USD Million) By Country (2018-2022)

Figure 16 Asia Pacific Medical Morphine Revenue (USD Million) By Type (2018-2022)

Figure 17 Asia Pacific Medical Morphine Revenue (USD Million) By Applications (2018-2022)

Figure 18 South America Medical Morphine Revenue (USD Million) By Country (2018-2022)

Figure 19 South America Medical Morphine Revenue (USD Million) By Type (2018-2022)

Figure 20 South America Medical Morphine Revenue (USD Million) By Applications (2018-2022)

Figure 21 Middle East and Africa Medical Morphine Revenue (USD Million) By Region (2018-2022)

Figure 22 Middle East and Africa Medical Morphine Revenue (USD Million) By Type (2018-2022)

Figure 23 Middle East and Africa Medical Morphine Revenue (USD Million) By Applications (2018-2022)

Figure 24 Global Medical Morphine Revenue (USD Million) By Type (2023-2030)

Figure 25 Global Medical Morphine Revenue Market Share (%) By Type (2030)

Figure 26 Global Medical Morphine Revenue (USD Million) By Applications (2023-2030)

Figure 27 Global Medical Morphine Revenue Market Share (%) By Applications (2030)

Figure 28 Global Medical Morphine Market Revenue (USD Million) By Regions (2023-2030)

Figure 29 North America Medical Morphine Revenue (USD Million) By Country (2023-2030)

Figure 30 North America Medical Morphine Revenue (USD Million) By Type (2023-2030)

Figure 31 North America Medical Morphine Revenue (USD Million) By Applications (2023-2030)

Figure 32 Europe Medical Morphine Revenue (USD Million) By Country (2023-2030)

Figure 33 Europe Medical Morphine Revenue (USD Million) By Type (2023-2030)

Figure 34 Europe Medical Morphine Revenue (USD Million) By Applications (2023-2030)

Figure 35 Asia Pacific Medical Morphine Revenue (USD Million) By Country (2023-2030)

Figure 36 Asia Pacific Medical Morphine Revenue (USD Million) By Type (2023-2030)

Figure 37 Asia Pacific Medical Morphine Revenue (USD Million) By Applications (2023-2030)

Figure 38 South America Medical Morphine Revenue (USD Million) By Country (2023-2030)

Figure 39 South America Medical Morphine Revenue (USD Million) By Type (2023-2030)

Figure 40 South America Medical Morphine Revenue (USD Million) By Applications (2023-2030)

Figure 41 Middle East and Africa Medical Morphine Revenue (USD Million) By Region (2023-2030)

Figure 42 Middle East and Africa Medical Morphine Revenue (USD Million) By Region (2023-2030)

Figure 43 Middle East and Africa Medical Morphine Revenue (USD Million) By Type (2023-2030)

Figure 44 Middle East and Africa Medical Morphine Revenue (USD Million) By Applications (2023-2030)

Figure 45 Bottom-Up and Top-Down Approaches For This Report

Figure 46 Data Triangulation

 

Medical Morphine Market Segmentation

By Dosage Form

• Injection
• Oral Tablets
• Others

 

By Application

• Pain Management
  • Cancer Pain
  • Neuropathic Pain
  • Osteoarthritis Pain
  • Others

• Diarrhea Suppressant
• Cold and Cough Suppressant
• Others

 

By Region

• North America (United States, Canada, Mexico)
• Europe (Germany, France, United Kingdom, Spain, Italy, Others)
• Asia Pacific (China, India, Japan, South Korea, Australia, Others)
• Latin America (Brazil, Argentina, Others)
• Middle East and Africa (Saudi Arabia, UAE, Kuwait, Other Middle East, South Africa, Nigeria, Other Africa)